Private Trust Company’s Repligen RGEN Stock Holding History

Private Trust Company’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-92	Closed	-$12.3K	–	2648
2025 Q3	$12.3K	Buy	92 +2	+2%	+$243	﹤0.01%	1827
2025 Q2	$11.2K	Sell	90 -15	-14%	-$1.91K	﹤0.01%	1781
2025 Q1	$13.4K	Buy	105 +21	+25%	+$3.23K	﹤0.01%	1705
2024 Q4	$12.1K	Buy	84 +8	+11%	+$1.15K	﹤0.01%	1691
2024 Q3	$11.3K	Buy	76 +8	+12%	+$1.15K	﹤0.01%	1671
2024 Q2	$8.57K	Sell	68 -9	-12%	-$1.41K	﹤0.01%	1736
2024 Q1	$14.2K	Hold	77	–	–	﹤0.01%	1539
2023 Q4	$13.8K	Buy	77 +3	+4%	+$467	﹤0.01%	1535
2023 Q3	$11.8K	Hold	74	–	–	﹤0.01%	1539
2023 Q2	$10.5K	Buy	74 +17	+30%	+$2.73K	﹤0.01%	1607
2023 Q1	$9.6K	Buy	57 +5	+10%	+$892	﹤0.01%	1595
2022 Q4	$9K	Hold	52	–	–	﹤0.01%	1599
2022 Q3	$10K	Hold	52	–	–	﹤0.01%	1462
2022 Q2	$8K	Buy	+52	New	+$8.22K	﹤0.01%	1597

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Private Trust Company's RGEN Position: Q4 2025 in Review

Private Trust Company sold out of Repligen (RGEN) in Q4 2025, closing a stake of 92 shares — an estimated $12.3K sold.

Private Trust Company first reported a position in RGEN in Q2 2022 and held it in 14 quarters. The position peaked at $14.2K in Q1 2024. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

Private Trust Company reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
Private Trust Company sold 92 Repligen shares in Q4 2025, an estimated $12.3K.
Private Trust Company first reported a position in Repligen in Q2 2022 and held it in 14 quarters.
Private Trust Company's Repligen position peaked at $14.2K in Q1 2024.
474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.